Walleye Trading’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-35,873
| Closed | -$1.03M | – | 1759 |
|
|
2024
Q2 | $1.03M | Buy |
35,873
+14,006
| +64% | +$401K | ﹤0.01% | 422 |
|
|
2024
Q1 | $639K | Buy |
+21,867
| New | +$639K | ﹤0.01% | 580 |
|
|
2023
Q4 | – | Sell |
-222
| Closed | -$6.81K | – | 2240 |
|
|
2023
Q3 | $6.81K | Buy |
+222
| New | +$6.81K | ﹤0.01% | 1391 |
|
|
2023
Q1 | – | Sell |
-7,001
| Closed | -$270K | – | 2207 |
|
|
2022
Q4 | $270K | Sell |
7,001
-1,196
| -15% | -$46.2K | ﹤0.01% | 933 |
|
|
2022
Q3 | $436K | Buy |
8,197
+1,681
| +26% | +$89.4K | ﹤0.01% | 798 |
|
|
2022
Q2 | $380K | Sell |
6,516
-1,312
| -17% | -$76.5K | ﹤0.01% | 862 |
|
|
2022
Q1 | $597K | Buy |
7,828
+3,067
| +64% | +$234K | ﹤0.01% | 639 |
|
|
2021
Q4 | $286K | Buy |
+4,761
| New | +$286K | ﹤0.01% | 1052 |
|
|
2021
Q3 | – | Sell |
-4,531
| Closed | -$275K | – | 2299 |
|
|
2021
Q2 | $275K | Buy |
+4,531
| New | +$275K | ﹤0.01% | 1005 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1616 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1698 |
|
|
2019
Q3 | – | Sell |
-1,136
| Closed | -$49K | – | 1613 |
|
|
2019
Q2 | $49K | Buy |
+1,136
| New | +$49K | ﹤0.01% | 918 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1619 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1951 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2132 |
|
|
2017
Q3 | – | Sell |
-1
| Closed | – | – | 1567 |
|
|
2017
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1850 |
|
|
2017
Q1 | – | Sell |
-31,077
| Closed | -$1M | – | 2096 |
|
|
2016
Q4 | $1M | Buy |
31,077
+30,576
| +6,103% | +$988K | 0.01% | 360 |
|
|
2016
Q3 | $17K | Buy |
+501
| New | +$17K | ﹤0.01% | 1371 |
|
|
2016
Q1 | – | Sell |
-1,100
| Closed | -$84K | – | 2314 |
|
|
2015
Q4 | $84K | Buy |
+1,100
| New | +$84K | ﹤0.01% | 1053 |
|